7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Clinical application value of metagenomic next-generation sequencing in the diagnosis of spinal infections and its impact on clinical outcomes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This study aimed to evaluate the impact of precise treatment administered according to the results of metagenomic next-generation sequencing (mNGS) on the clinical outcomes of patients with spinal infections. In this multicenter retrospective study, the clinical data of 158 patients with spinal infections who were admitted to Xiangya Hospital Central South University, Xiangya Boai Rehabilitation Hospital, The First Hospital of Changsha, and Hunan Chest Hospital from 2017 to 2022 were reviewed. Among these 158 patients, 80 patients were treated with targeted antibiotics according to the mNGS results and were assigned to the targeted medicine (TM) group. The remaining 78 patients with negative mNGS results and those without mNGS and negative microbial culture results were treated with empirical antibiotics and assigned to the empirical drug (EM) group. The impact of targeted antibiotics based on the mNGS results on the clinical outcomes of patients with spinal infections in the two groups was analyzed. The positive rate of mNGS for diagnosing spinal infections was significantly higher than that of microbiological culture ( X 2=83.92, P<0.001), procalcitonin ( X 2=44.34, P<0.001), white blood cells ( X 2=89.21, P < 0.001), and IGRAs (Interferon-gamma Release Tests) ( X 2 = 41.50, P < 0.001). After surgery, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) showed a decreasing trend in the patients with spinal infections in both the TM and EM groups. The decrease in CRP was more obvious in the TM group than in the EM group at 7, 14 days, 3, and 6 months after surgery ( P<0.05). The decrease in ESR was also significantly obvious in the TM group compared with the EM group at 1 and 6 months after surgery ( P<0.05). The time taken for CRP and ESR to return to normal in the TM group was significantly shorter than that in the EM group ( P<0.05). There was no significant difference in the incidence of poor postoperative outcomes between the two groups. The positive rate of mNGS for the diagnosis of spinal infection is significantly higher than that of traditional detection methods. The use of targeted antibiotics based on mNGS results could enable patients with spinal infections to achieve a faster clinical cure.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice

          Metagenomic next-generation sequencing (mNGS) was suggested to potentially replace traditional microbiological methodology because of its comprehensiveness. However, clinical experience with application of the test is relatively limited.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Tuberculosis

            Tuberculosis remains the leading cause of death from an infectious disease among adults worldwide, with more than 10 million people becoming newly sick from tuberculosis each year. Advances in diagnosis, including the use of rapid molecular testing and whole-genome sequencing in both sputum and non-sputum samples, could change this situation. Although little has changed in the treatment of drug-susceptible tuberculosis, data on increased efficacy with new and repurposed drugs have led WHO to recommend all-oral therapy for drug-resistant tuberculosis for the first time ever in 2018. Studies have shown that shorter latent tuberculosis prevention regimens containing rifampicin or rifapentine are as effective as longer, isoniazid-based regimens, and there is a promising vaccine candidate to prevent the progression of infection to the disease. But new tools alone are not sufficient. Advances must be made in providing high-quality, people-centred care for tuberculosis. Renewed political will, coupled with improved access to quality care, could relegate the morbidity, mortality, and stigma long associated with tuberculosis, to the past.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Understanding the Promises and Hurdles of Metagenomic Next-Generation Sequencing as a Diagnostic Tool for Infectious Diseases

              Metagenomic next-generation sequencing (mNGS) has emerged as a promising single, universal pathogen detection method for infectious disease diagnostics. With the development of mNGS assays, it is essential for treating practitioners to understand both the power and limitations of the method as a diagnostic tool.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Cell Infect Microbiol
                Front Cell Infect Microbiol
                Front. Cell. Infect. Microbiol.
                Frontiers in Cellular and Infection Microbiology
                Frontiers Media S.A.
                2235-2988
                08 February 2023
                2023
                : 13
                : 1076525
                Affiliations
                [1] 1 Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University , Changsha, China
                [2] 2 Department of Clinical Laboratory, Xiangya Hospital, Central South University , Changsha, China
                [3] 3 National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University , Changsha, China
                [4] 4 Department of Scientific Affaires,Guangzhou Sagene Biotechnology Company, Limited , Guangzhou, China
                Author notes

                Edited by: Floriana Campanile, University of Catania, Italy

                Reviewed by: Zeynep Ture, Erciyes University, Türkiye; Sathyavathi Sundararaju, Sidra Medicine, Qatar; Madjid Morsli, Aix Marseille Université, France

                *Correspondence: Qile Gao, gaoql@ 123456csu.edu.cn

                This article was submitted to Clinical Microbiology, a section of the journal Frontiers in Cellular and Infection Microbiology

                Article
                10.3389/fcimb.2023.1076525
                9945583
                36844401
                4ed490ce-7caa-4671-9b2b-891654b3d78d
                Copyright © 2023 Zhang, Zhang, Hu, Xu, Tang, Tang, Liu, Li, Xu, Guo and Gao

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 21 October 2022
                : 27 January 2023
                Page count
                Figures: 8, Tables: 3, Equations: 0, References: 19, Pages: 11, Words: 5898
                Funding
                Funded by: National Natural Science Foundation of China , doi 10.13039/501100001809;
                Funded by: National Natural Science Foundation of China , doi 10.13039/501100001809;
                Funded by: Natural Science Foundation of Hunan Province , doi 10.13039/501100004735;
                Funded by: Natural Science Foundation of Hunan Province , doi 10.13039/501100004735;
                The study was supported by National Natural Science Foundation of China (No. 82072460, 82170901); Natural Science Foundation of Hunan Province (No. 2020JJ4892, 2020JJ4808).
                Categories
                Cellular and Infection Microbiology
                Original Research

                Infectious disease & Microbiology
                metagenomic next-generation sequencing,diagnosis,spinal infection,traditional,prognosis

                Comments

                Comment on this article